Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold
- 1 April 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (7) , 1908-1911
- https://doi.org/10.1016/j.bmcl.2007.01.036
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Discovery and Development of 5-[(5S,9R)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1Journal of Medicinal Chemistry, 2006
- De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffoldBioorganic & Medicinal Chemistry Letters, 2005
- Modulating T cell responses for the treatment of psoriasis: a focus on efalizumabExpert Opinion on Biological Therapy, 2003
- Structures of the αL I Domain and Its Complex with ICAM-1 Reveal a Shape-Shifting Pathway for Integrin RegulationPublished by Elsevier ,2003
- Mechanisms contributing to the activity of integrins on leukocytesImmunological Reviews, 2002
- Anti-adhesion antibodiesTransplant Immunology, 2002
- Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin siteNature Medicine, 2001
- Novel p-Arylthio Cinnamides as Antagonists of Leukocyte Function-Associated Antigen-1/Intracellular Adhesion Molecule-1 Interaction. 2. Mechanism of Inhibition and Structure-Based Improvement of Pharmaceutical PropertiesJournal of Medicinal Chemistry, 2001
- Inhibitors of LFA-1/ICAM-1 interaction: From monoclonal antibodies to small moleculesDrugs of the Future, 2001
- The Leukocyte IntegrinsJournal of Biological Chemistry, 2000